Pharmsville Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Pharmsville.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Personal Products earnings growth | 30.2% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | None |
| Last updated | n/a |
Recent future growth updates
No updates
Recent updates
Pharmsville's (KOSDAQ:318010) Sluggish Earnings Might Be Just The Beginning Of Its Problems
Mar 28
Pharmsville (KOSDAQ:318010) Has A Pretty Healthy Balance Sheet
Mar 31We're Watching These Trends At Pharmsville (KOSDAQ:318010)
Mar 03Pharmsville's (KOSDAQ:318010) Shareholders Are Down 20% On Their Shares
Feb 10
Factors Income Investors Should Consider Before Adding Pharmsville Co., Ltd. (KOSDAQ:318010) To Their Portfolio
Jan 20Here's Why Pharmsville (KOSDAQ:318010) Can Manage Its Debt Responsibly
Dec 24Is Pharmsville Co., Ltd. (KOSDAQ:318010) A High Quality Stock To Own?
Nov 26In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Pharmsville has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2023 | 21,395 | 3,310 | 4,451 | 4,651 | N/A |
| 9/30/2023 | 22,923 | 3,609 | 4,788 | 5,119 | N/A |
| 6/30/2023 | 24,682 | 4,179 | 5,474 | 5,681 | N/A |
| 3/31/2023 | 26,208 | 4,386 | 6,134 | 6,266 | N/A |
| 12/31/2022 | 26,113 | 4,063 | 5,059 | 5,203 | N/A |
| 9/30/2022 | 26,426 | 3,279 | 4,503 | 4,775 | N/A |
| 6/30/2022 | 28,417 | 4,147 | 5,594 | 5,870 | N/A |
| 3/31/2022 | 33,678 | 4,928 | 7,407 | 7,721 | N/A |
| 12/31/2021 | 39,028 | 5,000 | 7,948 | 8,273 | N/A |
| 9/30/2021 | 42,349 | 4,518 | 8,259 | 8,359 | N/A |
| 6/30/2021 | 41,466 | 2,876 | 4,510 | 4,823 | N/A |
| 3/31/2021 | 39,673 | 2,186 | 86 | 1,301 | N/A |
| 12/31/2020 | 39,409 | 2,891 | -3,480 | 69 | N/A |
| 9/30/2020 | 38,932 | 5,483 | -4,909 | 1,123 | N/A |
| 6/30/2020 | 38,995 | 6,811 | -4,362 | 4,217 | N/A |
| 3/31/2020 | 36,331 | 8,257 | -2,931 | 5,352 | N/A |
| 12/31/2019 | 29,952 | 7,256 | -1,181 | 5,664 | N/A |
| 3/31/2019 | 19,025 | 4,169 | 2,385 | 4,298 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if A318010's forecast earnings growth is above the savings rate (2.5%).
Earnings vs Market: Insufficient data to determine if A318010's earnings are forecast to grow faster than the KR market
High Growth Earnings: Insufficient data to determine if A318010's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if A318010's revenue is forecast to grow faster than the KR market.
High Growth Revenue: Insufficient data to determine if A318010's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if A318010's Return on Equity is forecast to be high in 3 years time